JMDC Inc
TSE:4483

Watchlist Manager
JMDC Inc Logo
JMDC Inc
TSE:4483
Watchlist
Price: 3 864 JPY -1.1% Market Closed
Market Cap: 252.6B JPY
Have any thoughts about
JMDC Inc?
Write Note

Gross Margin
JMDC Inc

59.5%
Current
58%
Average
47.1%
Industry

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
59.5%
=
Gross Profit
22.5B
/
Revenue
37.8B

Gross Margin Across Competitors

Country JP
Market Cap 252.5B JPY
Gross Margin
59%
Country US
Market Cap 35.3B USD
Gross Margin
74%
Country US
Market Cap 31.3B USD
Gross Margin
83%
Country AU
Market Cap 26.1B AUD
Gross Margin
100%
Country US
Market Cap 10.9B USD
Gross Margin
90%
Country US
Market Cap 6.5B USD
Gross Margin
67%
Country JP
Market Cap 927.9B JPY
Gross Margin
58%
Country US
Market Cap 5.6B USD
Gross Margin
85%
Country SE
Market Cap 53.2B SEK
Gross Margin
47%
Country US
Market Cap 2.4B EUR
Gross Margin
66%
Country CN
Market Cap 15.9B CNY
Gross Margin
43%
No Stocks Found

JMDC Inc
Glance View

Market Cap
252.5B JPY
Industry
Health Care

Amidst the complex intersection of healthcare and technology, JMDC Inc. has carved a unique niche by harnessing the power of big data to improve healthcare outcomes and efficiency. Founded in Japan, the company stands as a beacon in the health informatics sector, meticulously collecting and analyzing health-related data drawn from a variety of sources, including medical claims, health screenings, and electronic health records. By transforming this extensive data trove into actionable insights, JMDC offers healthcare providers, pharmaceutical companies, and insurance firms the analytics they need to make informed decisions. Key to JMDC's operation is its commitment to safeguarding patient anonymity while extracting valuable insights that can streamline healthcare delivery, enhance pharmaceutical research, and optimize insurance underwriting. JMDC's revenue model hinges on the sale of its aggregated data and analytics solutions to a vast array of stakeholders in the medical field. Pharmaceutical companies, eager to understand drug efficacy and patient demographics better, turn to JMDC for data-driven insights that can influence drug development and marketing strategies. Insurance companies leverage JMDC's data to refine their offerings and better assess risk, ensuring competitive pricing models and improved customer satisfaction. Moreover, healthcare providers utilize this analytics backbone to enhance operational efficiency and improve patient care outcomes. Through licensing agreements and subscription-based services, JMDC effectively monetizes its data resources, achieving sustained growth in an industry that increasingly values the marriage of technology and healthcare.

Intrinsic Value
3 587.97 JPY
Overvaluation 7%
Intrinsic Value
Price

See Also

Discover More
What is Gross Margin?

Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.

Gross Margin
59.5%
=
Gross Profit
22.5B
/
Revenue
37.8B
What is the Gross Margin of JMDC Inc?

Based on JMDC Inc's most recent financial statements, the company has Gross Margin of 59.5%.